OCULAR THERAPEUTIX INC. - COMMON STOCK

Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting

03 فبراير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR

14 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation

08 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

13 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference

10 ديسمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1

02 ديسمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences

26 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights

14 نوفمبر 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV

13 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer

12 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024

06 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

28 أكتوبر 2024 10:00:04 بحسب NetDania Notify

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

21 أكتوبر 2024 09:47:37 بحسب NetDania Notify

NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK

16 أكتوبر 2024 15:33:40 بحسب NetDania Notify

Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD

15 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

09 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at October Ophthalmology Meetings

09 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024

25 سبتمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire